Business Description
InBody Co Ltd
ISIN : KR7041830001
Compare
Compare
Traded in other countries / regions
041830.Korea IPO Date
2000-12-14Description
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.41 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.16 | |||||
| Interest Coverage | 97.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 8.12 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17 | |||||
| 3-Year EBITDA Growth Rate | 26.5 | |||||
| 3-Year EPS without NRI Growth Rate | 27.1 | |||||
| 3-Year FCF Growth Rate | 5.6 | |||||
| 3-Year Book Growth Rate | 18.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.1 | |||||
| 9-Day RSI | 51.5 | |||||
| 14-Day RSI | 48.55 | |||||
| 6-1 Month Momentum % | -12.43 | |||||
| 12-1 Month Momentum % | -2.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.69 | |||||
| Quick Ratio | 5.31 | |||||
| Cash Ratio | 4.23 | |||||
| Days Inventory | 276.55 | |||||
| Days Sales Outstanding | 40.84 | |||||
| Days Payable | 32.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.53 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| 3-Year Dividend Growth Rate | 35.7 | |||||
| Forward Dividend Yield % | 1.53 | |||||
| 5-Year Yield-on-Cost % | 4.9 | |||||
| Shareholder Yield % | 1.32 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 77.93 | |||||
| Operating Margin % | 18.81 | |||||
| Net Margin % | 16.63 | |||||
| FCF Margin % | 13.18 | |||||
| ROE % | 12.46 | |||||
| ROA % | 11.01 | |||||
| ROIC % | 16.11 | |||||
| ROC (Joel Greenblatt) % | 33.71 | |||||
| ROCE % | 15.59 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.35 | |||||
| Forward PE Ratio | 7.04 | |||||
| PE Ratio without NRI | 9.48 | |||||
| Price-to-Owner-Earnings | 7.04 | |||||
| PEG Ratio | 0.59 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.11 | |||||
| Price-to-Free-Cash-Flow | 11.8 | |||||
| Price-to-Operating-Cash-Flow | 8.63 | |||||
| EV-to-EBIT | 4.67 | |||||
| EV-to-EBITDA | 4 | |||||
| EV-to-Revenue | 1 | |||||
| EV-to-FCF | 7.44 | |||||
| Price-to-Projected-FCF | 0.53 | |||||
| Price-to-DCF (Earnings Based) | 0.34 | |||||
| Price-to-DCF (FCF Based) | 0.91 | |||||
| Price-to-Median-PS-Value | 0.53 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.6 | |||||
| Price-to-Graham-Number | 0.68 | |||||
| Price-to-Net-Current-Asset-Value | 2.17 | |||||
| Price-to-Net-Cash | 4.02 | |||||
| Earnings Yield (Greenblatt) % | 21.42 | |||||
| FCF Yield % | 8.61 | |||||
| Forward Rate of Return (Yacktman) % | 24.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InBody Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 191,303.918 | ||
| EPS (TTM) (â‚©) | 2443 | ||
| Beta | 0.82 | ||
| Volatility % | 27.48 | ||
| 14-Day RSI | 48.55 | ||
| 14-Day ATR (â‚©) | 755.376045 | ||
| 20-Day SMA (â‚©) | 22900 | ||
| 12-1 Month Momentum % | -2.52 | ||
| 52-Week Range (â‚©) | 20850 - 30700 | ||
| Shares Outstanding (Mil) | 12.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
InBody Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
InBody Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
InBody Co Ltd Frequently Asked Questions
What is InBody Co Ltd(XKRX:041830)'s stock price today?
The current price of XKRX:041830 is â‚©22850.00. The 52 week high of XKRX:041830 is â‚©30700.00 and 52 week low is â‚©20850.00.
When is next earnings date of InBody Co Ltd(XKRX:041830)?
The next earnings date of InBody Co Ltd(XKRX:041830) is .
Does InBody Co Ltd(XKRX:041830) pay dividends? If so, how much?
The Dividend Yield %  of InBody Co Ltd(XKRX:041830) is 1.53% (As of Today), Highest Dividend Payout Ratio of InBody Co Ltd(XKRX:041830) was 0.15. The lowest was 0.06. And the median was 0.09. The  Forward Dividend Yield % of InBody Co Ltd(XKRX:041830) is 1.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers